Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Telomerase inhibitor].

S Kyo1, M Inoue

  • 1Dept. of Obstetrics and Gynecology, Kanazawa University School of Medicine.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|June 1, 2001
PubMed
Summary
This summary is machine-generated.

Telomerase, an enzyme critical for cell immortality and cancer, is a promising target for gene therapy. This review explores methods to inhibit telomerase activity in cancer cells for potential clinical use.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[MR imaging evaluation of plica synoviallis mediopatellaris of the knee joint].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

Histogenetic analysis of ovarian germ cell tumors by DNA fingerprinting.

Cancer research·1992
Same author

Changing patterns of cancer mortality among the elderly population in Japan.

Japanese journal of clinical oncology·1992
Same author

Sex determination by discriminant function analysis of lateral cranial form.

Forensic science international·1992
Same author

[Electrophysiologic study of cibenzoline in patients with paroxysmal atrial fibrillation with special reference to atrial fibrillation threshold].

Kokyu to junkan. Respiration & circulation·1992
Same author

Crystal structure of papain-succinyl-Gln-Val-Val-Ala-Ala-p-nitroanilide complex at 1.7-A resolution: noncovalent binding mode of a common sequence of endogenous thiol protease inhibitors.

Biochemistry·1992
Same journal

[A Case of Pulmonary Epithelioid Hemangioendothelioma Associated with Multiple Cancers].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Long-Term Survival in Three Cases with Pulmonary Metastases from Colorectal Cancer Given Low-Dose S-1 Under a Regimen Combining a Carbohydrate-Restricted Ketogenic Diet, Metformin, Vitamin D, Eicosapentaenoic Acid, and Other Complementary Therapies].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Preventive Effect of Saline Eye Wash for Eye Symptoms Due to High-Dose and Intermediate-Dose Cytarabine Therapy].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Examination of Factors Affecting the Efficacy of Naldemedine Tosilate Tablets for Opioid-Induced Constipation].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[Recent Advances in the Treatment of HER2-Altered Solid Tumors].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
Same journal

[BRAF-Mutant Solid Tumor].

Gan to kagaku ryoho. Cancer & chemotherapy·2026
See all related articles

Area of Science:

  • Molecular biology
  • Oncology
  • Biochemistry

Background:

  • Telomerase is a ribonucleoprotein enzyme responsible for maintaining telomere length at chromosome ends.
  • Telomere maintenance by telomerase confers cellular immortality and is implicated in carcinogenesis.
  • Telomerase is typically activated in malignant tumors but repressed in normal tissues, making it a key factor in cancer progression.

Purpose of the Study:

  • To review molecular techniques for inhibiting telomerase activity in cancer cells.
  • To identify methods with potential for clinical application in cancer gene therapy.

Main Methods:

  • Review of various molecular techniques targeting telomerase.
  • Analysis of methods for efficient inhibition of telomerase activity.

Related Experiment Videos

Main Results:

  • Telomerase activation is a critical step in cancer progression.
  • Several molecular techniques can effectively inhibit telomerase activity in cancer cells.

Conclusions:

  • Telomerase is a viable target for cancer gene therapy.
  • The reviewed methods show potential for clinical application in inhibiting cancer cell growth.